8-K
filed May 1, 2023, 7:59 PM ET
ticker JNJ
CIK 0000200406
leadership
confidence high
sentiment neutral
materiality 0.55
Thibaut Mongon leaving JNJ executive roles after Kenvue IPO; annual meeting results announced
JOHNSON & JOHNSON
- Thibaut Mongon to step down as EVP, WW Chairman Consumer Health and Executive Committee member upon Kenvue IPO closing; remains Kenvue CEO.
- All 12 Johnson & Johnson director nominees elected at annual meeting; each received >1.68B votes in favor.
- Shareholders approved advisory say-on-pay (1.685B for, 123M against) and set frequency at 1 year until 2029.
- Ratification of PwC as independent auditor for FY2023 passed with 2.049B votes for, 119M against.
- Two shareholder proposals—Vaccine Pricing Report and Extended Patent Exclusivities Report—were rejected by wide margins.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thibaut Mongon departed as Executive Vice President, Worldwide Chairman, Consumer Health at JOHNSON & JOHNSON.
- Action
- will cease to be
- Role
- Executive Vice President, Worldwide Chairman, Consumer Health
Exact text from the filing
Upon the closing of the initial public offering of Kenvue Inc., Thibaut Mongon will cease to be Executive Vice President, Worldwide Chairman, Consumer Health and member of the Executive Committee of Johnson & Johnson and will continue his role as Chief Executive Officer of Kenvue Inc.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
JOHNSON & JOHNSON shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2023-04-27 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Advisory Vote to Approve Named Executive Officer Compensation: For Against Abstained Non-Votes 1,685,320,654 123,275,647 11,076,730 353,172,322
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
JOHNSON & JOHNSON shareholders approved Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation at the 2023-04-27 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation: For 1 Year For 2 Years For 3 Years Abstained Non-Votes 1,785,566,411 4,955,319 22,089,730 7,061,571 353,172,322
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
JOHNSON & JOHNSON shareholders rejected Shareholder Proposal - Impact of Extended Patent Exclusivities on Product Access at the 2023-04-27 meeting.
- Outcome
- failed
- Meeting
- 2023-04-27
Exact text from the filing
Shareholder Proposal - Impact of Extended Patent Exclusivities on Product Access: For Against Abstained Non-Votes 258,032,003 1,530,773,877 30,867,151 353,172,322
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
JOHNSON & JOHNSON shareholders approved Election of Directors at the 2023-04-27 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Election of Directors: Shares For Shares Against Shares Abstain Non-Votes D. Adamczyk 1,786,272,387 16,426,067 16,974,577 353,172,322 M. C. Beckerle 1,789,457,274 13,764,941 16,450,816 353,172,322 D. S. Davis 1,756,303,275 46,470,790 16,898,966 353,172,322 J. A. Doudna 1,789,027,330 14,257,035 16,388,666 353,172,322 J. Duato 1,688,009,715 120,870,955 10,792,361 353,172,322 M. A. Hewson 1,773,472,628 29,649,436 16,550,967 353,172,322 P. A. Johnson 1,804,950,345 9,856,598 4,866,088 353,172,322 H. Joly 1,772,344,027 30,395,092 16,933,912 353,172,322 M. B. McClellan 1,788,586,733 14,265,282 16,821,016 353,172,322 A. M. Mulcahy 1,698,043,017 104,917,215 16,712,799 353,172,322 M. A. Weinberger 1,788,359,732 14,280,263 17,033,036 353,172,322 N. Y. West 1,793,769,456 9,125,005 16,778,570 353,172,322
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
JOHNSON & JOHNSON shareholders approved Ratification of Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for 2023 at the 2023-04-27 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Ratification of Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for 2023 : For Against Abstained Non-Votes 2,048,852,179 118,621,657 5,371,517 (0)
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
JOHNSON & JOHNSON shareholders rejected Shareholder Proposal - Vaccine Pricing Report at the 2023-04-27 meeting.
- Outcome
- failed
- Meeting
- 2023-04-27
Exact text from the filing
Shareholder Proposal - Vaccine Pricing Report: For Against Abstained Non-Votes 569,515,836 1,223,800,230 26,356,965 353,172,322
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.